147 related articles for article (PubMed ID: 11033338)
21. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
Meiergerd SM; McElvain JS; Schenk JO
Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
[TBL] [Abstract][Full Text] [Related]
22. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
23. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
24. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
Xu C; Reith ME
J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
[TBL] [Abstract][Full Text] [Related]
25. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
[No Abstract] [Full Text] [Related]
26. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
27. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology and regulation of the neuronal dopamine transporter.
Reith ME; Xu C; Chen NH
Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
[TBL] [Abstract][Full Text] [Related]
29. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
[TBL] [Abstract][Full Text] [Related]
30. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.
Wang JB; Moriwaki A; Uhl GR
J Neurochem; 1995 Mar; 64(3):1416-9. PubMed ID: 7861176
[TBL] [Abstract][Full Text] [Related]
31. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.
Whitehead RE; Ferrer JV; Javitch JA; Justice JB
J Neurochem; 2001 Feb; 76(4):1242-51. PubMed ID: 11181843
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML
J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910
[TBL] [Abstract][Full Text] [Related]
33. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications.
Kuhar MJ
Ciba Found Symp; 1992; 166():81-9; discussion 89-95. PubMed ID: 1638923
[TBL] [Abstract][Full Text] [Related]
34. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
[No Abstract] [Full Text] [Related]
35. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
36. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
37. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Dutta AK; Coffey LL; Reith ME
J Med Chem; 1997 Jan; 40(1):35-43. PubMed ID: 9016326
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
39. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.
Izenwasser S; Newman AH; Katz JL
Eur J Pharmacol; 1993 Oct; 243(2):201-5. PubMed ID: 8276070
[TBL] [Abstract][Full Text] [Related]
40. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
